Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 February 2024 | Story Lacea Loader | Photo SUPPLIED
Prof Prince Ngobeni
Prof Prince Ngobeni, newly appointed Campus Principal of the UFS Qwaqwa Campus.

The University of the Free State (UFS) has appointed Prof Prince Ngobeni as Principal of the Qwaqwa Campus as from 1 February 2024.

Prof Ngobeni completed his first qualification in Analytical Chemistry at the then Technikon North-West before furthering his studies at the then Technikon Pretoria. He completed a DTech in Chemistry at the Tshwane University of Technology (TUT) in 2003. In 2016, he enrolled for a Doctor of Business Administration in Higher Education at the University of Bath in England. 

His lecturing career began at TUT in 1995 where he progressed from Head of Department: Chemistry in 2003 to Associate Dean: Faculty of Science in 2010, before being appointed as Executive Dean of the Faculty of Sciences at TUT in 2015 – a position he held until 2023. He also served as Interim Campus Rector of TUT’s Pretoria Campus from 2018 to 2020.

“With extensive years of academic leadership experience, Prof Ngobeni has the experience required to guide the Qwaqwa Campus towards the university’s Vision 130. The campus is already recognised as a leader in some of its unique research fields, and Prof Ngobeni’s strong research background will be valuable in this regard,” says Prof Francis Petersen, Vice-Chancellor and Principal of the UFS. 

Prof Ngobeni is a member of several professional bodies in his field of expertise, including MatTEK at the Council for Scientific and Industrial Research (CSIR), the South African Chemical Institute (SACI), the Society for Atomic Spectroscopy, and the South African Council for Natural Scientific Professions (SACNASP). During his career, he has also secured research funding for individual projects and international partnerships. Prof Ngobeni also initiated chemistry practical sessions for local schools and participated in the Technology Station in Chemicals project, which offers a wide range of services designed to assist small and medium enterprises (SMEs) in the chemical sector.

His substantial list of publications in journals and books covers a range of chemistry-related and managerial topics. He is also a well-versed presenter at local and international conferences. 

“The Qwaqwa Campus has experienced major developments in recent years; I look forward to further contributing to the growth of the campus and to support the university in achieving its Vision 130,” says Prof Ngobeni. 

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept